Clinic

With our TCD academic teaching hospitals (St James's, Tallaght  & St Patrick's University Hospitals), the Health Service Executive (HSE) and our service users our vision is to improve evidence-based clinical care.

 

We are running a clinical trial of cognitive remediation  therapy based on promising preliminary data that this can help people with schizophrenia to function better in daily life.

 

We coordinate the Dublin arm for a national clinical trial (headed by Dr Maeve Rooney from UCC) on the efficacy of Omega-3 in people at high risk of developing schizophrenia.

 

We are investigating the diagnostic importance of auto-antibodies in first episode psychosis. This prospective study, running in conjunction with local clinical services, will be completed in mid-2016.

 

 

 

 

 

Computerized working-memory focused cognitive remediation therapy for psychosis: a preliminary study

Hargreaves A, et al.

Nature Neuroscience, 2015

In this large collaborative study we show that common risk variants aggregate in biological pathways and that these pathways are shared between schizophrenia, bipolar disorder and depression.